Allergan - 26 Year Stock Split History | AGN

Stock split history for Allergan since 1993. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Allergan Annual Stock Splits
Allergan Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $54.453B $15.787B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Mylan (MYL) United Kingdom $10.983B 4.84
Teva Pharmaceutical Industries (TEVA) Israel $8.506B 3.34
Bausch Health Cos (BHC) Canada $8.160B 5.44
Dr Reddy's Laboratories (RDY) India $6.323B 21.27
ASPEN PHARMACR (APNHY) South Africa $2.946B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.505B 14.72
Amphastar Pharmaceuticals (AMPH) United States $1.002B 49.35
Homology Medicines (FIXX) United States $0.943B 0.00
Voyager Therapeutics (VYGR) United States $0.669B 0.00
Akorn (AKRX) United States $0.473B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.470B 0.00
CymaBay Therapeutics (CBAY) United States $0.385B 0.00
Assembly Biosciences (ASMB) United States $0.381B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.213B 0.29
Zynerba Pharmaceuticals (ZYNE) United States $0.205B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.184B 0.00
Sol-Gel Technologies (SLGL) Israel $0.162B 0.00
Teligent (TLGT) United States $0.052B 0.00
China Pharma Holdings (CPHI) China $0.012B 0.00